Title : Small molecule anticancer drugs.

Pub. Date : 1999 Jun

PMID : 16127615






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 There is a lot of interest in targeting cyclin-dependent kinases (cdk): flavopiridol (Hoechst AG), a broad-spectrum inhibitor of cdk1, cdk2 and cdk4 is now entering phase II trials. alvocidib cyclin dependent kinase 1 Homo sapiens
2 There is a lot of interest in targeting cyclin-dependent kinases (cdk): flavopiridol (Hoechst AG), a broad-spectrum inhibitor of cdk1, cdk2 and cdk4 is now entering phase II trials. alvocidib cyclin dependent kinase 1 Homo sapiens